Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fampridine for Upper Limb Function in Progressive MS
NCT02208050Phase 4Completed
- Sponsor
- University College Dublin
- Start
- Feb 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dalfampridine in Secondary Progressive Multiple Sclerosis (SPMS), primary progressive multiple sclerosis (PPMS), sponsored by University College Dublin. Started Feb 2014; status: completed.
02
Drugs
dalfampridine
03
Conditions
Secondary Progressive Multiple Sclerosis (SPMS)primary progressive multiple sclerosis (PPMS)
Beyond the preview
Go deeper on NCT02208050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02208050.